Cross Country Healthcare Files 8-K on Shareholder Votes

Ticker: CCRN · Form: 8-K · Filed: 2025-12-11T00:00:00.000Z

Sentiment: neutral

Topics: shareholder-vote, corporate-governance, 8-k

Related Tickers: CCRH

TL;DR

CCRH filed an 8-K on Dec 11 for a Dec 9 shareholder vote.

AI Summary

Cross Country Healthcare, Inc. filed an 8-K on December 11, 2025, reporting on matters submitted to a vote of security holders as of December 9, 2025. The filing details the company's corporate information, including its principal executive office in Boca Raton, Florida, and its status as a Delaware corporation.

Why It Matters

This filing indicates that Cross Country Healthcare, Inc. held or is holding a vote of its security holders, which could pertain to significant corporate decisions or governance matters.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not contain information suggesting immediate financial or operational risks.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Cross Country Healthcare, Inc. security holders on or around December 9, 2025?

The filing does not specify the exact matters voted upon, only that 'Submission of Matters to a Vote of Security Holders' is the item reported.

When was the Form 8-K filed with the SEC?

The Form 8-K was filed on December 11, 2025.

Where is Cross Country Healthcare, Inc.'s principal executive office located?

The principal executive office is located at 5201 Congress Avenue, Suite 160, Boca Raton, FL 33487.

Under which state is Cross Country Healthcare, Inc. incorporated?

Cross Country Healthcare, Inc. is incorporated in Delaware.

What is the company's SEC file number?

The company's SEC file number is 0-33169.

From the Filing

0001628280-25-056541.txt : 20251211 0001628280-25-056541.hdr.sgml : 20251211 20251211161854 ACCESSION NUMBER: 0001628280-25-056541 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20251209 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20251211 DATE AS OF CHANGE: 20251211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services EIN: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 251565216 BUSINESS ADDRESS: STREET 1: 5201 CONGRESS AVENUE, SUITE 160 CITY: BOCA RATON STATE: FL BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 5201 CONGRESS AVENUE, SUITE 160 CITY: BOCA RATON STATE: FL FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 8-K 1 ccrn-20251209.htm 8-K ccrn-20251209 0001141103 FALSE 0001141103 2025-12-09 2025-12-09 0001141103 dei:FormerAddressMember 2025-12-09 2025-12-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 9, 2025 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 5201 Congress Avenue, Suite 160 , Boca Raton , FL 33487 (Address of Principal Executive Office) (Zip Code) ( 561 ) 998-2232 (Registrant’s telephone number, including area code) 6 551 Park of Commerce Boulevard, N.W. , Boca Raton , FL 33487 (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act:     Title of each class                 Trading Symbol         Name of each exchange on which registered Common stock, par value $0.0001 per share          CCRN              The Nasdaq Stock Market LLC Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.07    Submission of Matters to a Vote of Security Holders (a) On December 9, 2025, the Company held its Annual Meeting of Stockholders (“Annual Meeting”). (b) The following items of business were voted upon by stockholders at the Annual Meeting: (i) A proposal to elect the directors listed below for a one-year term ending in 2026 or until their successors are duly elected and q

View on Read The Filing